Literature DB >> 2900209

Factor XIIIa and the classic histiocytic markers in malignant fibrous histiocytoma: a comparative immunohistochemical study.

Z Nemes1, V Thomázy.   

Abstract

Fifteen cases of malignant fibrous histiocytoma (MFH) and 79 cases of differential-diagnostically related soft tissue tumors were evaluated for immunoreactive cells for the subunit A of factor XIII (F-XIIIa) in comparison with the staining obtained by the classic histiocytic markers: lysozyme, alpha 1-antitrypsin (AAT) and alpha 1-antichymotrypsin (AACT). Ubiquitous and focal staining patterns were distinguished. Only three cases of MFH were characterized by an ubiquitous positive reaction for AAT and AACT, in contrast to the obligatory positive staining of MFH for F-XIIIa. This low ratio is probably related to the high proportion of predominantly fibroblastic and myxoid types of MFH (11/15). In the three cases of MFH characterized by ubiquitous positive reactions for both antiproteases and for F-XIIIa, the frequency of positive cells for AAT and AACT exceeded that for F-XIIIa. Thus, the positive cells for antiproteases and those for F-XIIIa represent different levels of fibro-histiocytic differentiation; the F-XIIIa-positive cells are fibro-histiocyte precursors. F-XIIIa-positive stromal cells are present in the normal mesenchyme, but their significance is unknown. The fact that these cells are a constant feature of MFH argues for a histiocytic pathway of their differentiation. The ubiquitous presence of F-XIIIa-positive cells in MFH distinguishes them from the histologically similar soft tissue tumors. However, the focal presence of F-XIIIa-positive cells indicate only a host response to an unspecified tissue injury that may occur in all kinds of soft tissue tumors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900209     DOI: 10.1016/s0046-8177(88)80266-1

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

1.  Dermal dendrocytes and photochemotherapy.

Authors:  G E Piérard; A Nikkels; J Arrese Estrada; T Ben Mosbah; C Piérard-Franchimont
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  Comparative immunohistochemistry of malignant fibrous histiocytoma and sarcomatoid carcinoma of the urinary tract.

Authors:  Y Hasui; S Nishi; S Kitada; Y Osada; A Sumiyoshi
Journal:  Urol Res       Date:  1991

3.  The spindle-shaped cells in cutaneous Kaposi's sarcoma. Histologic simulators include factor XIIIa dermal dendrocytes.

Authors:  B J Nickoloff; C E Griffiths
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

4.  Osteoclast-like giant cell tumour of the gallbladder.

Authors:  M Ito; C T Hsu; S Naito; T Matsuo; S Onizuka; I Sekine; H Fujii; Y Matsuoka
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

5.  A practical and comprehensive immunohistochemical approach to the diagnosis of superficial soft tissue tumors.

Authors:  Wael Al-Daraji; Ehab Husain; Bettena G Zelger; Bernhard Zelger
Journal:  Int J Clin Exp Pathol       Date:  2008-06-10

6.  Factor XIIIA subunit and Crohn's disease.

Authors:  M Hudson; A J Wakefield; R A Hutton; E A Sankey; A P Dhillon; L More; R Sim; R E Pounder
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

7.  Ontogeny and characterization of factor XIIIa+ cells in developing human skin.

Authors:  N S Gibran; B J Nickoloff; K A Holbrook
Journal:  Anat Embryol (Berl)       Date:  1996-01

8.  The distribution of factor XIIIa-positive cells in the human fetus and placenta.

Authors:  C L Trimble; M H Gray; N S McNutt
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

9.  Characterization of a dermal derived malignant mesenchymal tumor arising in ultraviolet irradiated mice.

Authors:  R G Phelps; L E Bernstein; N Harpaz; R E Gordon; F A Cruickshank; E Schwartz
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

10.  Primary malignant fibrous histiocytoma of the renal pelvis: a 78-month follow-up case report.

Authors:  Yuebing Chen; Dapang Rao; Haibo Zhu; Haifeng Yu; Shikun Yang
Journal:  Onco Targets Ther       Date:  2013-12-17       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.